Skip to content
PHOENIX-Logo
  • Home
  • Company
    • About Us
    • Our Board
    • Our Milestones
    • Our Collaborators
  • Technology & Products
    • Confidentiality of Technology and Products
    • OPAL Process
    • OPAL A
    • Intellectual Property
    • Future Patents
  • Scientific & Clinical
    • Confidentiality of Results of Scientific & Clinical Research
    • Scientific Research
    • Clinical Research
  • Publications & Presentations
    • Confidentiality of Publications & Presentations
    • Published Academic Papers
    • Conference Presentations
    • Poster Presentations
    • Published Articles
    • Clinical Reports
  • Contact Us
×
  • Home
  • Company
    • About Us
    • Our Board
    • Our Milestones
    • Our Collaborators
  • Technology & Products
    • Confidentiality of Technology and Products
    • OPAL Process
    • OPAL A
    • Intellectual Property
    • Future Patents
  • Scientific & Clinical
    • Confidentiality of Results of Scientific & Clinical Research
    • Scientific Research
    • Clinical Research
  • Publications & Presentations
    • Confidentiality of Publications & Presentations
    • Published Academic Papers
    • Conference Presentations
    • Poster Presentations
    • Published Articles
    • Clinical Reports
  • Contact Us

Poster Presentations

Home » Publications » Poster Presentations

Philpott M, Rzechorzek N, Woodward M, & Mitchell G, Cysteine Proteases May Play a Role in the Wound Healing Properties of OPAL A; Australian Wound Management Association Conference, Gold Coast, Queensland, May 2014

Woodward M, Woolley M & Richardson M, Randomised, placebo-controlled study of OPAL A for the treatment and management of chronic venous and pressure ulcers; Australian Wound Management Association Conference, Gold Coast, Queensland, May 2014

Nowicki J & Siviour A, Enzymatic debridement: A failed promise, or hope for the future?; Australian Wound Management Association Conference, Gold Coast, Queensland, May 2014

Russell F, Windegger T, Cheetham N & Mitchell G, Inhibition of 5-lipoxygenase activity by the novel wound-healing agent OPAL A; Australasian Wound & Tissue Repair Society Conference, Perth, Western Australia, March 2010

Mitchell G & Tozer L, Treatment of Chronic Wounds with Alkalised Fruit Extract – Case Series, Australian Wound Management Association Conference; Perth, Western Australia, March 2010

Mitchell G & Woodward M, The treatment of vascular ulcers with alkalised fruit extract; European Wound Management Conference, Helsinki, Finland, March 2009

PHOENIX

Phoenix Eagle is a biopharmaceutical research and development company with a robust product pipeline based on its unique OPAL technology

Quick Links

  • Home
  • Company
  • Technology and Products
  • Scientific & Clinical Research
  • Publications & Presentations
  • Contact Us

Contact Us

Phoenix Eagle Company Pty Ltd
Suite 5
531 Hay Street
Subiaco, WA 6008
Australia
Tel: 0419 094 748
Email: business@phoenixeaglecompany.com

© 2023 Phoenix Eagle Company. All Rights Reserved. Site by DeCODE | Privacy Policy